Aristeia Capital’s CVS Health CVS Stock Holding History

Aristeia Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$579K	Buy	8,066 +1,874	+30%	+$144K	0.01%	334
2025 Q4	$491K	Buy	+6,192	New	+$488K	0.01%	329

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aristeia Capital's CVS Position: Q1 2026 in Review

Aristeia Capital increased its CVS Health (CVS) stake by 30% in Q1 2026, buying an estimated $144K and bringing the position to 8,066 shares worth $579K. The position accounts for 0.01% of the portfolio, ranked #334.

Aristeia Capital first reported a position in CVS in Q4 2025 and has held it in 2 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Aristeia Capital held 8,066 shares of CVS Health worth $579K as of Q1 2026.
Aristeia Capital bought 1,874 CVS Health shares in Q1 2026, an estimated $144K.
CVS Health made up 0.01% of Aristeia Capital's portfolio in Q1 2026, its #334 holding.
Aristeia Capital first reported a position in CVS Health in Q4 2025 and has held it in 2 quarters since.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Aristeia Capital's 13F filing for Q1 2026, filed 15 May 2026.